You are here
Jun 2015 The inaugural Cord Blood Industry Report from the Parent's Guide to Cord Blood Foundation reveals that sibling transplants for thalassemia are becoming the dominant allogeneic therapy with cord blood from family banks. An allogeneic therapy is any therapy where the cord blood is used for a person other than the baby from which it originated. A pie chart of the cumulative allogeneic therapies through the end of 2013 is shown at left.
Jun 2015 AMTF (Afzaal Memorial Thalassemia Foundation) - Helping Blood Disorders is a charitable foundation that was launched in Palistan by Dr. Asim Qidwai and others to help children suffering with blood disorders.